Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 2:03 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1729–1752 of 3,925 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: HTN Clear all

Conditions: Primary Open Angle Glaucoma
Interventions: AMDX-2011P; Drug
Lead sponsor: Amydis Inc.; Industry
Eligibility: 22 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 3
States / cities: Phoenix, Arizona • Glendale, California • Newport Beach, California

Conditions: Primary Open Angle Glaucoma
Interventions: Not listed
Lead sponsor: Wills Eye; Other
Eligibility: 40 Years and older
Enrollment: 97 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Pulmonary Hypertension, Pulmonary Arterial Hypertension
Interventions: Ralinepag, Placebo; Drug
Lead sponsor: United Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 5
States / cities: Tucson, Arizona • Aurora, Colorado • Denver, Colorado + 2 more

Conditions: Pulmonary Arterial Hypertension
Interventions: [18F] FES; Drug
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older · Female only
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Hypertension
Interventions: Eplerenone, Amlodipine, Microneurography, Rhythmic handgrip exercise, Sustained hand grip, Forearm blood flow, Arm cycling exercise, Cold Pressor test; Drug · Procedure
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2021
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Hypertension
Interventions: Potassium Magnesium Citrate (KMgCit), Potassium Chloride (KCl), Chlorthalidone; Drug
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 21 Years and older
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2022
U.S. locations: 3
States / cities: Dallas, Texas

Conditions: Hypertension
Interventions: Lifestyle Modifications; Behavioral
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Beachwood, Ohio

Conditions: Hypertension
Interventions: Chronotherapy; Drug
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years to 70 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2010
U.S. locations: 1
States / cities: Great Neck, New York

Conditions: Preeclampsia, Maternal Hypertension
Interventions: NIRS based personalized blood pressure management; Device
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: New York, New York

Conditions: Pre Hypertension, Hypertension
Interventions: Dietary capsules; Dietary Supplement
Lead sponsor: Skidmore College; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Saratoga Springs, New York

Conditions: Hypertension
Interventions: Not listed
Lead sponsor: Tiba Medical, Inc.; Industry
Eligibility: 3 Years and older
Enrollment: 105 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Glaucoma
Interventions: Observation only; Other
Lead sponsor: Peregrine Ophthalmic; Industry
Eligibility: 18 Years to 99 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Goose Creek, South Carolina

Conditions: Preeclampsia
Interventions: acetylsalicylic acid; Drug
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years to 60 Years · Female only
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 2
States / cities: New York, New York

Conditions: Hypertension, Chronic Kidney Disease
Interventions: DASH Diet, Control Diet; Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Glaucoma; Drugs, Normal Tension Glaucoma, Primary Open-angle Glaucoma
Interventions: Timolol Maleate, Brimonidine Tartrate; Drug
Lead sponsor: Wills Eye; Other
Eligibility: 18 Years to 90 Years
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Hypertension, Blood Pressure, Overweight and Obesity
Interventions: clinical decision support; Other
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 3 Years to 18 Years
Enrollment: 2,803 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Pre-Eclampsia, Depression, Inflammation, Vitamin D Deficiency
Interventions: mental health screening, education and referral program; Other
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2027
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Hypertension, Resistant Hypertension
Interventions: MobiusHD, Sham Implantation; Device · Other
Lead sponsor: Vascular Dynamics, Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2025
U.S. locations: 5
States / cities: Atlanta, Georgia • Springfield, Illinois • Indianapolis, Indiana + 2 more

Conditions: Hypertension
Interventions: optima4BP; Other
Lead sponsor: Optima Integrated Health; Industry
Eligibility: 21 Years to 80 Years
Enrollment: 165 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Hypertension
Interventions: Self-affirmation intervention; Behavioral
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2005
U.S. locations: 1
States / cities: New York, New York

Conditions: Hypertension
Interventions: Improve clinic based measurement of blood pressure, Provider education system to promote patient-centered care, Introduce care management system in clinics; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 66,570 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Masked Hypertension
Interventions: Carvedilol, Amlodipine; Drug
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years to 75 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Hypertension
Interventions: Real PPL, Sim PPL; Behavioral
Lead sponsor: HealthPartners Institute; Other
Eligibility: 22 Years and older
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Hypertension
Interventions: HBPStories; Behavioral
Lead sponsor: University of Delaware; Other
Eligibility: 18 Years and older
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Newark, Delaware

Search by objective public record fields.

A Study of AMDX-2011P in Participants With Primary Open Angle Glaucoma

How Does Your Genetic Make-up (Profile) Influence Your Glaucoma?

Study of Ralinepag on Exercise Capacity by Cardiopulmonary Exercise Testing (CPET) in WHO Group 1 PH Subjects

[18F]FES PET/CT in PAH

The Role of Aldosterone on Augmented Exercise Pressor Reflex in Hypertension

Preventing Metabolic Side Effects of Thiazide Diuretics With KMgCitrate

Home Blood Pressure Monitoring to Improve Hypertension

Post Kidney Transplant Nocturnal Hypertension Prevalence and Management Study

PROtecting Maternal Brains From Injury and Stroke

Impact of Sex in the Effect of Dietary Capsaicin on Cardiovascular Health

Clinical Validation of the Tiba Medical Ambulo 2400 ABPM According to the ISO 80601-2-30 Standard in Adults, Adolescents, and Children

Open Label Extension of LipoLat-CS202

Low Doses of Aspirin in the Prevention of Preeclampsia

Efficacy and Safety of the DASH Diet in Adults With Moderate Chronic Kidney Disease: Pilot Study

Peripapillary Blood Flow After Use of Anti-glaucoma Medications: An OCT Angiography Study

Clinical-Decision Support to Improve Hypertension Care in Primary Care

Preeclampsia Research on Vitamin D, Inflammation, & Depression

CALM- 2 - Controlling and Lowering Blood Pressure With the MobiusHD™

Tailored Drug Titration Using Artificial Intelligence

The Association Between the Use of Complementary and Alternative Medicine and Medication Adherence in Hypertensive African-Americans

Multi-Method Health System Quality Improvement Intervention to Reduce Hypertension Disparities

Mechanism of Masked Hypertension - Intervention

Personalized Physician Learning to Improve Hypertension Care

Storytelling Intervention for African Americans Living With Hypertension